Correlation Between MediciNova and Spero Therapeutics
Can any of the company-specific risk be diversified away by investing in both MediciNova and Spero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MediciNova and Spero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MediciNova and Spero Therapeutics, you can compare the effects of market volatilities on MediciNova and Spero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MediciNova with a short position of Spero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of MediciNova and Spero Therapeutics.
Diversification Opportunities for MediciNova and Spero Therapeutics
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between MediciNova and Spero is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and Spero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spero Therapeutics and MediciNova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MediciNova are associated (or correlated) with Spero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spero Therapeutics has no effect on the direction of MediciNova i.e., MediciNova and Spero Therapeutics go up and down completely randomly.
Pair Corralation between MediciNova and Spero Therapeutics
Given the investment horizon of 90 days MediciNova is expected to under-perform the Spero Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, MediciNova is 1.42 times less risky than Spero Therapeutics. The stock trades about -0.19 of its potential returns per unit of risk. The Spero Therapeutics is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest 86.00 in Spero Therapeutics on November 28, 2024 and sell it today you would lose (6.56) from holding Spero Therapeutics or give up 7.63% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
MediciNova vs. Spero Therapeutics
Performance |
| Timeline |
| MediciNova |
| Spero Therapeutics |
MediciNova and Spero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MediciNova and Spero Therapeutics
The main advantage of trading using opposite MediciNova and Spero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MediciNova position performs unexpectedly, Spero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will offset losses from the drop in Spero Therapeutics' long position.| MediciNova vs. Aerovate Therapeutics | MediciNova vs. Adagene | MediciNova vs. Acrivon Therapeutics, Common | MediciNova vs. Rezolute |
| Spero Therapeutics vs. Assembly Biosciences | Spero Therapeutics vs. Achilles Therapeutics PLC | Spero Therapeutics vs. Instil Bio | Spero Therapeutics vs. CytomX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |